Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
UTI diagnostic stewardship can improve antibiotic stewardship
, /in Featured Articles, Urine Analysis /by panglobalIt could be easy to imagine that the gold standard for diagnosis of urinary tract infection (UTI) is urine culturing with antimicrobial susceptibility testing to ensure prescription of the correct antibiotic. However, there are many aspects to the diagnosis of a UTI and an overreliance on urine culture alone can result in asymptomatic bacteriuria being […]
Integra Biosciences launches $10.000 Future Lab Grant competition to modernise laboratory workflows
, /in E-News /by panglobalINTEGRA Biosciences has announced a competitive grant programme offering laboratories the opportunity to win $10,000 worth of pipetting and automation equipment to address operational challenges and enhance experimental efficiency.
Roche introduces sixth-generation troponin T test with enhanced diagnostic precision
, /in Product News /by panglobalRoche has unveiled results from its comprehensive TSIX Study Program evaluating a new high-sensitivity cardiac troponin T assay designed to improve acute myocardial infarction diagnosis in emergency settings. The sixth-generation test, recently granted CE Mark approval, demonstrates significant advances in sensitivity and accuracy for detecting cardiac events.
Takara Bio launches defined medium for high-yield extracellular vesicle production
, /in Product News /by panglobalTakara Bio Europe has introduced Cellartis® MSC EV Wonder™, a chemically defined, xeno-free culture medium designed to address scalability challenges in mesenchymal stem cell-derived extracellular vesicle (MSC-EV) manufacturing. The product targets researchers developing cell-free therapeutic candidates for regenerative medicine and immunomodulation applications.
SynGenSys unveils NK.SET synthetic promoter library for natural killer cell therapies
, /in Product News /by panglobalSynGenSys has introduced NK.SET™, the first commercially available synthetic promoter library designed specifically for natural killer (NK) cell immunotherapies. The Sheffield-based biotechnology company’s announce-ment marks a significant validation of its platform for engineering tissue-specific gene regulation control elements.
Bio-Rad launches consolidated specialty immunoassay quality control in Europe
, /in Product News /by panglobalBio-Rad launches consolidated specialty immunoassay quality control in Europe Bio-Rad Laboratories has introduced its Specialty Immunoassay Plus (SPIA Plus) control system to European clinical laboratories, offering enhanced quality monitoring capabilities for specialty immunoassay testing procedures.
Amsbio expands CAR-T research tools with sterile cell line portfolio
, /in Product News /by panglobalAmsbio has launched an expanded portfolio of ready-to-use, sterile cell lines designed to accelerate CAR-T cell therapy research for leukaemia treatment. The offering addresses growing demand for standardised cellular tools following the 2017 FDA approval of CAR-T therapy for children and adolescents with B cell acute lymphoblastic leukaemia (ALL).
Thermo Fisher Scientific unveils spectralunmixing beads for enhanced flow cytometry precision
, /in Product News /by panglobalThermo Fisher Scientific has introduced Invitrogen UltraComp eBeads Spectral Unmixing Beads, a next-generation com-pensation tool designed to improve signal accuracy in spectral and conventional flow cytometry applications. The product addresses persistent challenges in fluoro-chrome separation and background inter-ference that can compromise data quality in multi-parameter cellular analysis.
Nilo Therapeutics secures $101 million to develop neural circuit-targeted immuno-modulatory therapies
, /in No Category /by panglobalNilo Therapeutics has launched with $101 million in Series A financing to develop therapies that target the brain’s control of immune responses, marking a significant departure from conventional approaches to autoimmune and inflammatory disease treatment. The funding round, led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and […]
ACD/Labs and Covestro launch AI-powered solvent selection tool for pharmaceutical research
, /in E-News /by panglobalAdvanced Chemistry Development (ACD/Labs) and materials science company Covestro have unveiled a collaborative project integrating artificial intelligence into solvent selection processes for pharmaceutical and chemical research. The partnership, announced at the PhysChem Forum 2025 in Basel, Switzerland, combines computational chemistry expertise with software development to address long-standing inefficiencies in laboratory workflows.